RADA16 for Adult Tonsillectomy
Recruiting now · Phase 3
Conditions studied: Postoperative Pain
In brief
The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy hemorrhage. Participants will: * Undergo tonsillectomy procedure. * Receive and fill out a survey sent via email every 2 days following their procedure for 15 days and track their symptoms.
Key facts
- Study ID
- NCT07060495
- Run by
- Rutgers, The State University of New Jersey
- People needed
- 134
- Starts
- 2025-09-12
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-07-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults undergoing tonsillectomy (CPT codes)
You may not qualify if…
- Patients undergoing adenoidectomy or uvulopalatopharyngoplasty in addition to tonsillectomy
- Patients who have had prior tonsillectomy or tonsillotomy
- Patient undergoing tonsillectomy with concern for malignancy
- Patients who are on opioids chronically prior to surgery
- Patients with an additional indication for pain management (i.e. unrelated to tonsillectomy)
- Patients who have been diagnosed with a bleeding disorder or hematologic malignancy
- Patients who are on anticoagulants
- The following at-risk populations:
- Anyone under age 18
- Pregnant women
- Prisoners
- Adults unable to consent (anyone lacking capacity)
Where it is running
- Cooperman Barnabas Medical Center — Livingston, New Jersey, United States (enrolling)
- University Hospital — Newark, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.